Literature DB >> 8874254

Detection of Mycoplasma pneumoniae by polymerase chain reaction in lung aspirates from patients with community-acquired pneumonia.

M Falguera1, A Nogues, A Ruiz-Gonzalez, M Garcia, T Puig.   

Abstract

STUDY
OBJECTIVE: This study was designed to evaluate the usefulness of polymerase chain reaction (PCR) to detect Mycoplasma pneumoniae DNA in samples obtained by transthoracic needle aspiration (TNA).
DESIGN: Prospective study of cases.
SETTING: A university hospital in Lleida, Spain. PATIENTS: A total of 101 unselected patients, admitted between January 1993 and March 1994 in the emergency department, with a clinical and radiologic picture of community-acquired pneumonia, and without contraindications for TNA application.
INTERVENTIONS: Patients were studied with conventional diagnostic techniques for community-acquired pneumonia. In addition, a sample obtained by TNA was processed by the following methods: culture in standard media, culture in selective media for Legionella, detection of capsular antigens for Streptococcus pneumoniae and Haemophilus influenzae, and detection of M pneumoniae specific genome by PCR.
RESULTS: Serologic data were not available in eight patients and were excluded from this analysis. M pneumoniae PCR amplification was possible in eight cases, well correlated with serologic responses indicating current infection. Samples from ten additional patients, negative by PCR, were found to be demonstrative of recent M pneumoniae infection by serologic study. Finally, in all the remaining 75 cases, including the 59 patients for whom a different microbial diagnosis was established, M pneumoniae PCR test gave negative results.
CONCLUSION: This study indicates that PCR, applied to samples obtained by TNA, appears to be a moderately sensitive and highly specific method for rapid detection of M pneumoniae lung infection.

Entities:  

Mesh:

Year:  1996        PMID: 8874254     DOI: 10.1378/chest.110.4.972

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  7 in total

Review 1.  Molecular diagnosis of Mycoplasma pneumoniae respiratory tract infections.

Authors:  K Loens; D Ursi; H Goossens; M Ieven
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

2.  Community epidemiology of Chlamydia and Mycoplasma pneumoniae in LRTI in France over 29 months.

Authors:  Jacques Gaillat; Antoine Flahault; Bertille deBarbeyrac; Jeanne Orfila; Henri Portier; Jean-Pierre Ducroix; Christiane Bébéar; Charles Mayaud
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 3.  Diagnosis of infectious diseases: a cytopathologist's perspective.

Authors:  C N Powers
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

4.  Clinical use of capillary PCR to diagnose Mycoplasma pneumonia.

Authors:  J Honda; T Yano; M Kusaba; J Yonemitsu; H Kitajima; M Masuoka; K Hamada; K Oizumi
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

5.  Development of a genomics-based PCR assay for detection of Mycoplasma pneumoniae in a large outbreak in New York State.

Authors:  A L Waring; T A Halse; C K Csiza; C J Carlyn; K Arruda Musser; R J Limberger
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

Review 6.  Mycoplasma pneumoniae and its role as a human pathogen.

Authors:  Ken B Waites; Deborah F Talkington
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

7.  Enhanced identification of viral and atypical bacterial pathogens in lower respiratory tract samples with nucleic acid amplification tests.

Authors:  Bonita E Lee; Joan L Robinson; Vinod Khurana; Xiaoli L Pang; Jutta K Preiksaitis; Julie D Fox
Journal:  J Med Virol       Date:  2006-05       Impact factor: 2.327

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.